Varian Medical Systems (VAR) to Release Earnings on Wednesday
Varian Medical Systems (NYSE:VAR) is scheduled to post its Q3112 quarterly earnings results on Wednesday, October 23rd. Analysts expect Varian Medical Systems to post earnings of $1.12 per share and revenue of $779.02 million for the quarter. Varian Medical Systems has set its FY13 guidance at $4.00-4.04 EPS.
Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.02. The company had revenue of $726.20 million for the quarter, compared to the consensus estimate of $749.01 million. During the same quarter last year, the company posted $0.96 earnings per share. Varian Medical Systems’s revenue was up 3.0% compared to the same quarter last year.
Varian Medical Systems (NYSE:VAR) traded down 1.09% during mid-day trading on Tuesday, hitting $77.375. 395,085 shares of the company’s stock traded hands. Varian Medical Systems has a 52-week low of $57.00 and a 52-week high of $80.66. The stock’s 50-day moving average is $75.21 and its 200-day moving average is $70.90. The company has a market cap of $8.330 billion and a price-to-earnings ratio of 19.69.
A number of analysts have recently weighed in on VAR shares. Analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note to investors on Monday, September 16th. They now have a $78.00 price target on the stock. Finally, analysts at Brean Capital raised their price target on shares of Varian Medical Systems from $76.00 to $80.00 in a research note to investors on Thursday, July 25th. They now have a “buy” rating on the stock. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company’s stock. Varian Medical Systems has a consensus rating of “Hold” and a consensus target price of $75.00.
In other Varian Medical Systems news, SVP Robert Kluge sold 13,889 shares of the company’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $78.00, for a total value of $1,083,342.00. Following the completion of the transaction, the senior vice president now directly owns 30,121 shares of the company’s stock, valued at approximately $2,349,438. The sale was disclosed in a document filed with the SEC, which is available at this link.
Varian Medical Systems, Inc is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy (NYSE:VAR), stereotactic radiosurgery (SRS) and brachytherapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.